Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Claudia Lasagni, Laura Bigi, Andrea Conti & Giovanni Pellacani. (2018) Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies. Journal of Dermatological Treatment 29:sup2, pages 5-8.
Read now
Read now
Uwe Wollina. (2017) Emerging treatments for pyoderma gangrenosum. Expert Opinion on Orphan Drugs 5:10, pages 827-832.
Read now
Read now
Articles from other publishers (4)
Ardea Milidrag, Medo Gutić, Ivana Rodić, Ana Pjevač, Tatjana Mladenović, Vesna Miličić & Ana Ravić-Nikolić. (2022) Adverse Effect in Patients with Psoriasis Treated with Interleukin 17A Inhibitor- Secukinumab. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Daiuske Ikuma, Masahiko Oguro, Junichi Hoshino, Hiroki Mizuno, Akinari Sekine, Masahiro Kawada, Rikako Hiramatsu, Keiichi Sumida, Eiko Hasegawa, Noriko Hayami, Masayuki Yamanouchi, Tatsuya Suwabe, Naoki Sawa, Kenmei Takaichi & Yoshifumi Ubara. (2019) Efficacy of Secukinumab for Plaque Psoriasis in a Patient on Hemodialysis. CEN Case Reports 9:1, pages 55-58.
Crossref
Crossref
Kelsey S. Flood, Martina L. Porter & Alexa B. Kimball. (2019) Biologic Treatment for Hidradenitis Suppurativa. American Journal of Clinical Dermatology 20:5, pages 625-638.
Crossref
Crossref
Ted George Achufusi, Prateek S. Harnee & Sekou Rawlins. (2019) A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab. Case Reports in Medicine 2019, pages 1-5.
Crossref
Crossref